Search
Upload
For you
Explore
Following
Log in
Company
About
Press
Jobs
Dailymotion Pro
Support
Developers
Advertisers
Accessibility
Help Center
Legal
Manage Cookies
Privacy and Cookie Policy
Legal notices
Terms
All videos
© 2026 Dailymotion
Add to Playlist
Report
Benzinga
Follow
Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation
2 years ago
Eli Lilly's valuation stands at $842 billion, 54x projected earnings. Orforglipron could be the first small-molecule weight-loss pill when it launches in 2026, giving Eli Lilly two-year lead before rivals catch
Category
🗞
News
Show less
Recommended
1:04
Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'
Benzinga
4:15
Something Is Happening In The Utilities Sector That Investors Should Watch Out For | $XLU
Benzinga
4:16
Piper's Sandler's Craig Johnson Puts $6,600 Target On $SPX For 2025
Benzinga
13:34
"The Second Half Of September Is When The Trouble Tends To Come" - Ryan Detrick, CMT, Carson Group
Benzinga
6:39
What turns around the value stocks?
Benzinga
4:07
Nike Q1 Earnings Highlights: EPS Beats As North American Sales Slide, Shares Move Higher
Benzinga
4:17
Apple Stock Dips After KeyBanc Cuts Rating On iPhone Sale Concerns: What Investors Need To Know
Benzinga
2:27
Boeing Dips In Pre-Market As Struggling Plane Maker Considers Raising $10B Through Stock Sale Amid Strike
Benzinga
1:00
Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
Benzinga
0:39
Apple Stock Drops 14% in 2025 As Growth, AI, And China Risks Weigh On Tech Giant
Benzinga
1:31
Why Is The Fed Still So Aggressive? - Jeremy Schwartz, Chief Investment Officer at WisdomTree
Benzinga
4:01
Is Japan The Right Country To Invest In Right Now? - Jeremy Schwartz, Global Chief Investment Officer @WisdomTreeFunds
Benzinga
New
0:59
Nvidia Rethinks AI Funding
Benzinga
1:00
Snowflake Jumps 8% Pre-Market After Piper Sander Hikes Price Target To $215, Calls It 'High-Conviction Growth Play'
Benzinga
3:04
How End Of Month Buy And Sell Imbalances Effected Stock Movements
Benzinga
2:45
Can The S&P 500 Reach $6000 Before Year End? | Jay Woods, CMT, Chief Global Strategist, Freedom Markets
Benzinga
5:17
Housing stocks Not As Quiet As People Think - $TPH $BZH $PHM
Benzinga
17:00
Volatility And Momentum In The Market - Cameron Dawson, CIO NewEdge Wealth
Benzinga
1:40
Is Managing Volatility Really An Asset Class?
Benzinga
1:24
Nike Stock Jumps On Q1 Earnings Beat- 'We Still Have Work Ahead'
Benzinga
1:04
Advanced Micro Devices Stock Pops On $6 Billion Buyback Plan, US Tariff Ease
Benzinga
1:12
Warren Buffett's Berkshire Hathaway, Elon Musk's Tesla And Eli Lilly Could Be Next Trillion-Dollar Companies After Nvidia's Rapid Ascension: Jim Cramer
Benzinga
0:58
Charlie Munger Revealed What Was Left On His Bucket List Before He Died
Benzinga
1:27
Jim Cramer Says Investors Should Check Share Count Before Buying A Stock: 'You Want A Management That Agrees With You'
Benzinga
8:50
Meta Revealed Behind $15B Kentucky Data Center as Residents Sue
Land4DataCenter